Login / Signup

Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end-stage renal disease on maintenance haemodialysis.

Sunil TanejaAjay Kumar DusejaManu MehtaArka DeNipun VermaMadhumita PremkumarRadha K DhimanVirendra SinghMini P SinghRadha K RathoRaja RamachandranVivek KumarHarbir S Kohli
Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)
Sofosbuvir plus Velpatasvir fixed-dose combination is safe and effective in treating CHC in patients with ESRD on MHD.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • peritoneal dialysis
  • hepatitis c virus
  • hepatitis c virus infection
  • liver fibrosis